Fingerpaint Group, a Cedar Knolls-based platform for the life sciences industry, announced the acquisition of L&M Healthcare Communications, a New Jersey-based medical communications agency. The strategic move enhances Fingerpaint Group’s comprehensive offering in medical communications and medical affairs, which the company has been robustly building over the last five years.
Details of the transaction were not disclosed.
L&M Healthcare Communications brings over two decades of experience serving leading biotech and pharmaceutical companies, with specialized expertise that will complement the offerings of Fingerpaint Medical, Fingerpaint Group’s medical communications arm.
The acquisition is particularly valuable for L&M’s strong capabilities in peer-to-peer educational programs and speaker bureau services. These services, which are critical for effective scientific exchange, will become part of Fingerpaint Medical’s portfolio.
“Welcoming L&M Healthcare Communications into our organization is a step toward the future we’re building in medical communications,” Javeria Shahab, president of Fingerpaint Medical said. “Their expertise… strengthens our ability to deliver innovative, more connected solutions.”
Since partnering with private equity firm Knox Lane in 2020, Fingerpaint Group has been on an aggressive growth path, leveraging strategic acquisitions to expand its capabilities, customer base, and talent pool.
Bill McEllen, global president of Fingerpaint Group, emphasized the importance of the acquisition, stating, “This acquisition strengthens our commercialization platform and is a key step in expanding our leadership in the medical communications space.”
Adam Margolis, chief executive officer and managing partner of L&M, confirmed that the L&M leadership team will remain with the business and work within Fingerpaint Medical. “Joining Fingerpaint Group is a defining moment for our team and the clients we serve,” Margolis said. “Now with access to Fingerpaint Group’s full suite of capabilities, we’re uniquely positioned to guide our clients through every stage of the product lifecycle and beyond.”
The combined entity aims to deliver smarter, science-driven services in a rapidly evolving health care industry, committed to supporting clients throughout the full product lifecycle.
